Heyman Richard A. — SEC insider filings

SEC reporting owner CIK 1584759. 60 insider filings on record with FilingPulse; latest filed 2026-10-02.

Transaction summary — filings shown

Covers the 50 most recent of 60 filings on record, filed 2021-06-04 to 2026-10-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Enliven Therapeutics, Inc. (ELVN)Director25—33 legs · 46,534 sh · $1,086,9649
Oric Pharmaceuticals, Inc. (ORIC)Director14—12 legs · 30,354 sh · $417,10515
PMV Pharmaceuticals, Inc. (PMVP)Director6——6
Gritstone bio, Inc. (GRTS)Director2——2
Metacrine, Inc. (MTCR)Director1——1
RayzeBio, Inc. (RYZB)Director1——1
YUMANITY THERAPEUTICS, INC. (YMTX)Director1——1

Insider filings — Heyman Richard A.

FiledFormIssuerReported transactionsSource
2026-10-024Oric Pharmaceuticals, Inc. (ORIC)Option exercise (M): 3,500 @ $1.60 · Sale (S): 3,500 @ $12.91 · Sale (S): 3,200 @ $12.91 · Option exercise (M): 3,500 (derivative) @ $0EDGAR
2026-07-284Oric Pharmaceuticals, Inc. (ORIC)Option exercise (M): 3,500 @ $1.60 · Sale (S): 7,000 @ $12.02 · Sale (S): 6,100 @ $12.02 · Option exercise (M): 3,500 (derivative) @ $0EDGAR
2026-07-084Oric Pharmaceuticals, Inc. (ORIC)Sale (S): 300 @ $12EDGAR
2026-02-194Enliven Therapeutics, Inc. (ELVN)Sale (S): 1,230 @ $26.18EDGAR
2026-02-174Enliven Therapeutics, Inc. (ELVN)Grant/award (A): 19,234 (derivative) @ $0EDGAR
2026-01-224Enliven Therapeutics, Inc. (ELVN)Sale (S): 512 @ $26.46 · Sale (S): 718 @ $26.96EDGAR
2026-01-204Oric Pharmaceuticals, Inc. (ORIC)Sale (S): 3,500 @ $12.00 · Sale (S): 3,200 @ $12.00EDGAR
2026-01-124Enliven Therapeutics, Inc. (ELVN)Sale (S): 1,620 @ $25 · Sale (S): 8,015 @ $25.04 · Sale (S): 4,285 @ $25.00EDGAR
2026-01-064Oric Pharmaceuticals, Inc. (ORIC)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2025-10-034Oric Pharmaceuticals, Inc. (ORIC)Option exercise (M): 31,353 @ $1.60 · Option exercise (M): 1,447 @ $3.75 · Option exercise (M): 13,228 (derivative) @ $0 · Option exercise (M): 18,125 (derivative) @ $0 · Option exercise (M): 1,447 (derivative) @ $0EDGAR
2025-06-094PMV Pharmaceuticals, Inc. (PMVP)Grant/award (A): 33,500 (derivative) @ $0EDGAR
2025-02-104Enliven Therapeutics, Inc. (ELVN)Grant/award (A): 23,014 (derivative) @ $0EDGAR
2025-01-064Oric Pharmaceuticals, Inc. (ORIC)Grant/award (A): 35,000 (derivative) @ $0EDGAR
2024-10-224Enliven Therapeutics, Inc. (ELVN)Sale (S): 817 @ $30.00 · Sale (S): 753 @ $30.00EDGAR
2024-10-174Enliven Therapeutics, Inc. (ELVN)Sale (S): 1,270 @ $27.67EDGAR
2024-10-084Enliven Therapeutics, Inc. (ELVN)Sale (S): 2,825 @ $27.51EDGAR
2024-10-034Enliven Therapeutics, Inc. (ELVN)Sale (S): 518 @ $27.54EDGAR
2024-09-184Enliven Therapeutics, Inc. (ELVN)Sale (S): 1,270 @ $22.41EDGAR
2024-08-194Enliven Therapeutics, Inc. (ELVN)Sale (S): 650 @ $22.82 · Sale (S): 620 @ $23.70EDGAR
2024-08-024Enliven Therapeutics, Inc. (ELVN)Sale (S): 1,702 @ $27.51 · Sale (S): 649 @ $27.50EDGAR
2024-07-174Enliven Therapeutics, Inc. (ELVN)Sale (S): 1,270 @ $24.80EDGAR
2024-06-204Enliven Therapeutics, Inc. (ELVN)Sale (S): 1,270 @ $21.48EDGAR
2024-06-144Oric Pharmaceuticals, Inc. (ORIC)Grant/award (A): 25,600 (derivative) @ $0EDGAR
2024-06-104PMV Pharmaceuticals, Inc. (PMVP)Grant/award (A): 67,500 (derivative) @ $0EDGAR
2024-05-204Enliven Therapeutics, Inc. (ELVN)Sale (S): 1,270 @ $23.74EDGAR
2024-04-154Enliven Therapeutics, Inc. (ELVN)Sale (S): 5,045 @ $25.03 · Sale (S): 1,190 @ $19.94 · Sale (S): 80 @ $20.68 · Sale (S): 649 @ $25EDGAR
2024-03-214Enliven Therapeutics, Inc. (ELVN)Sale (S): 1,270 @ $14.50EDGAR
2024-02-274RayzeBio, Inc. (RYZB)Disposition to issuer (D): 367,446 @ $62.50EDGAR
2024-02-204/AEnliven Therapeutics, Inc. (ELVN)Grant/award (A): 29,205 (derivative) @ $0EDGAR
2024-02-204Enliven Therapeutics, Inc. (ELVN)Sale (S): 1,270 @ $17.42EDGAR
2024-02-154Enliven Therapeutics, Inc. (ELVN)Grant/award (A): 21,043 (derivative) @ $0EDGAR
2024-02-014Enliven Therapeutics, Inc. (ELVN)Sale (S): 1,270 @ $16.41EDGAR
2023-12-264Enliven Therapeutics, Inc. (ELVN)Sale (S): 7 @ $13 · Sale (S): 6 @ $13 · Sale (S): 168 @ $13 · Sale (S): 35 @ $13EDGAR
2023-12-214Enliven Therapeutics, Inc. (ELVN)Sale (S): 255 @ $13 · Sale (S): 2,110 @ $13.02 · Sale (S): 1,915 @ $13.02EDGAR
2023-06-154Oric Pharmaceuticals, Inc. (ORIC)Grant/award (A): 20,500 (derivative) @ $0EDGAR
2023-06-124PMV Pharmaceuticals, Inc. (PMVP)Grant/award (A): 21,500 (derivative) @ $0EDGAR
2023-04-064Enliven Therapeutics, Inc. (ELVN)Grant/award (A): 34,458 (derivative) @ $0EDGAR
2023-02-274Enliven Therapeutics, Inc. (ELVN)Grant/award (A): 149,820 · Grant/award (A): 37,407 · Grant/award (A): 31,172 · Grant/award (A): 20,657 (derivative)EDGAR
2022-09-064Metacrine, Inc. (MTCR)Grant/award (A): 16,500 (derivative) @ $0EDGAR
2022-06-224Gritstone bio, Inc. (GRTS)Grant/award (A): 19,000 (derivative) @ $0EDGAR
2022-06-174Oric Pharmaceuticals, Inc. (ORIC)Grant/award (A): 53,700 (derivative) @ $0EDGAR
2022-06-064PMV Pharmaceuticals, Inc. (PMVP)Grant/award (A): 19,500 (derivative) @ $0EDGAR
2021-11-194Gritstone bio, Inc. (GRTS)Grant/award (A): 19,000 (derivative) @ $0EDGAR
2021-09-164Oric Pharmaceuticals, Inc. (ORIC)Sale (S): 706 @ $25.05 · Sale (S): 682 @ $25.03EDGAR
2021-09-144Oric Pharmaceuticals, Inc. (ORIC)Sale (S): 479 @ $25.10 · Sale (S): 601 @ $25.01EDGAR
2021-09-094Oric Pharmaceuticals, Inc. (ORIC)Sale (S): 1,086 @ $25.11EDGAR
2021-07-234PMV Pharmaceuticals, Inc. (PMVP)Grant/award (A): 5,781 (derivative) @ $0EDGAR
2021-06-174Oric Pharmaceuticals, Inc. (ORIC)Grant/award (A): 16,625 (derivative) @ $0EDGAR
2021-06-094PMV Pharmaceuticals, Inc. (PMVP)Grant/award (A): 16,333 (derivative) @ $0EDGAR
2021-06-044YUMANITY THERAPEUTICS, INC. (YMTX)Grant/award (A): 14,800 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-11-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1584759 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs